These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37514995)

  • 1. A Monoclonal Antibody Produced in Glycoengineered Plants Potently Neutralizes Monkeypox Virus.
    Esqueda A; Sun H; Bonner J; Lai H; Jugler C; Kibler KV; Steinkellner H; Chen Q
    Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild-type and glycoengineered Nicotiana benthamiana plants.
    Hurtado J; Acharya D; Lai H; Sun H; Kallolimath S; Steinkellner H; Bai F; Chen Q
    Plant Biotechnol J; 2020 Jan; 18(1):266-273. PubMed ID: 31207008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population.
    Feng Y; Zhang Y; Liu S; Guo M; Huang H; Guo C; Wang W; Zhang W; Tang H; Wan Y
    BMC Med; 2023 May; 21(1):183. PubMed ID: 37189197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants.
    Lai H; He J; Hurtado J; Stahnke J; Fuchs A; Mehlhop E; Gorlatov S; Loos A; Diamond MS; Chen Q
    Plant Biotechnol J; 2014 Oct; 12(8):1098-107. PubMed ID: 24975464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in L1 protein.
    Kaever T; Meng X; Matho MH; Schlossman A; Li S; Sela-Culang I; Ofran Y; Buller M; Crump RW; Parker S; Frazier A; Crotty S; Zajonc DM; Peters B; Xiang Y
    J Virol; 2014 Oct; 88(19):11339-55. PubMed ID: 25031354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
    Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB
    Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein.
    Su HP; Golden JW; Gittis AG; Hooper JW; Garboczi DN
    Virology; 2007 Nov; 368(2):331-41. PubMed ID: 17688903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27.
    Hughes LJ; Goldstein J; Pohl J; Hooper JW; Lee Pitts R; Townsend MB; Bagarozzi D; Damon IK; Karem KL
    Virology; 2014 Sep; 464-465():264-273. PubMed ID: 25108113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for a Plant-Made SARS-CoV-2 Neutralizing Monoclonal Antibody as a Synergetic Cocktail Component.
    Jugler C; Sun H; Grill F; Kibler K; Esqueda A; Lai H; Li Y; Lake D; Chen Q
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a rapid image-based high-content imaging screening assay to evaluate therapeutic antibodies against the monkeypox virus.
    Kota KP; Ziółkowska NE; Wei J; Peng J; Ordonez D; Raney C; Prigge J; Hooper JW; Awasthi M; Goebel SJ; Zabel BA; Nasar F; Lederman S; Bavari S
    Antiviral Res; 2023 Feb; 210():105513. PubMed ID: 36592670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity.
    Dent M; Hurtado J; Paul AM; Sun H; Lai H; Yang M; Esqueda A; Bai F; Steinkellner H; Chen Q
    J Gen Virol; 2016 Dec; 97(12):3280-3290. PubMed ID: 27902333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies.
    Wolffe EJ; Vijaya S; Moss B
    Virology; 1995 Aug; 211(1):53-63. PubMed ID: 7645236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12.
    Forthal DN; Gach JS; Landucci G; Jez J; Strasser R; Kunert R; Steinkellner H
    J Immunol; 2010 Dec; 185(11):6876-82. PubMed ID: 21041724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals.
    Zaeck LM; Lamers MM; Verstrepen BE; Bestebroer TM; van Royen ME; Götz H; Shamier MC; van Leeuwen LPM; Schmitz KS; Alblas K; van Efferen S; Bogers S; Scherbeijn S; Rimmelzwaan GF; van Gorp ECM; Koopmans MPG; Haagmans BL; GeurtsvanKessel CH; de Vries RD
    Nat Med; 2023 Jan; 29(1):270-278. PubMed ID: 36257333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans.
    Grifoni A; Zhang Y; Tarke A; Sidney J; Rubiro P; Reina-Campos M; Filaci G; Dan JM; Scheuermann RH; Sette A
    Cell Host Microbe; 2022 Dec; 30(12):1662-1670.e4. PubMed ID: 36463861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological responses to smallpox A33 antigen and monkeypox A35 antigen in healthy people and people living with HIV-1 from Guangzhou, China.
    Dai J; Li F; Yang Y; Tang X; Li L; Yu H
    J Med Virol; 2023 May; 95(5):e28763. PubMed ID: 37212313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile.
    Strasser R; Castilho A; Stadlmann J; Kunert R; Quendler H; Gattinger P; Jez J; Rademacher T; Altmann F; Mach L; Steinkellner H
    J Biol Chem; 2009 Jul; 284(31):20479-85. PubMed ID: 19478090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus.
    Gushchin VA; Ogarkova DA; Dolzhikova IV; Zubkova OV; Grigoriev IV; Pochtovyi AA; Iliukhina AA; Ozharovskaia TA; Kuznetsova NA; Kustova DD; Shelkov AY; Zrelkin DI; Odintsova AS; Grousova DM; Kan VY; Davtyan SA; Siniavin AE; Belyaeva ED; Botikov AG; Bessonova AA; Vasilchenko LA; Vasina DV; Kleymenov DA; Slutskiy EA; Tkachuk AP; Burgasova OA; Loginova SY; Rozhdestvensky EV; Shcheblyakov DV; Tsibin AN; Komarov AG; Zlobin VI; Borisevich SV; Naroditsky BS; Logunov DY; Gintsburg AL
    Front Immunol; 2022; 13():1023164. PubMed ID: 36466896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the Hemagglutinin Head Domain.
    Gao R; Sreenivasan CC; Sheng Z; Hause BM; Zhou B; Wentworth DE; Clement T; Rausch D; Brunick C; Christopher-Hennings J; Wu H; Bausch CL; Sullivan EJ; Hoppe AD; Huber VC; Wang D; Li F
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of plant-made monoclonal antibodies against viral infections.
    Chen Q
    Curr Opin Virol; 2022 Feb; 52():148-160. PubMed ID: 34933212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.